Australia - English - Department of Health (Therapeutic Goods Administration)

allied health group australia - 41481 - orthosis, leg, hip, - children hip braces for stabilisation and correction

Australia - English - Department of Health (Therapeutic Goods Administration)

allied biotech australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

allied biotech australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

allied biotech australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

allied biotech australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

allied biotech australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

allied distribution pty ltd - allium sativum,olea europaea -

United States - English - NLM (National Library of Medicine)

allied pharma inc - clarithromycin (unii: h1250jik0a) (clarithromycin - unii:h1250jik0a) - clarithromycin 250 mg - clarithromycin tablets are indicated for the treatment of mild to moderate infections caused by susceptible isolates of the designated bacteria in the conditions as listed below: adults pharyngitis/tonsillitis due to streptococcus pyogenes (the usual drug of choice in the treatment and prevention of streptococcal infections and the prophylaxis of rheumatic fever is penicillin administered by either the intramuscular or the oral route. clarithromycin is generally effective in the eradication of s. pyogenes from the nasopharynx; however, data establishing the efficacy of clarithromycin in the subsequent prevention of rheumatic fever are not available at present). acute maxillary sinusitis due to haemophilus influenzae , moraxella catarrhalis, or streptococcus pneumoniae . acute bacterial exacerbation of chronic bronchitis due to haemophilus influenzae , haemophilus parainfluenzae, moraxella catarrhalis, or streptococcus pneumoniae. community-acquired pneumonia due to haemophilus influenzae , mycop

Australia - English - Department of Health (Therapeutic Goods Administration)

allied int aust pty ltd - riboflavine, quantity: 850 microgram; garcinia hanburyi, quantity: 500 mg (equivalent: garcinia hanburyi, qty 2 g); thiamine hydrochloride, quantity: 750 microgram; pyridoxine hydrochloride, quantity: 1 mg; biotin, quantity: 150 microgram; cyanocobalamin, quantity: 3 microgram; folic acid, quantity: 100 microgram; nicotinic acid, quantity: 16 mg; pantothenic acid, quantity: 5 mg; chromic chloride hexahydrate, quantity: 50 microgram - capsule, hard - excipient ingredients: gelatin; sodium lauryl sulfate; purified water - nutrition and vitamin supplement. this product contains garcinia hanburyi (gambogia) which may suppress appetite to assist weight loss when used in conjunction with or as part of a kilojoule-calorie controlled eating plan.

Australia - English - Department of Health (Therapeutic Goods Administration)

allied biotech australia pty ltd -